![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, May 11, 2014 3:39:45 PM
- No significant revenue for years.
- A multi-year history of PR's claiming a constant stream of new distribution agreements all over the world, yet still no significant revenues.
- Repeated dilution.
- A loss in share value of over 98% since 2009.
- Repeated denials by the FDA including to DeNovo applications.
- Claims by management they are "waiting by the fax machine for FDA approval at any moment" (their words, not mine), approval which never materializes.
![](http://robnixon.com/wp-content/uploads/Multi-Partner-firm-head-in-the-sand1.jpg)
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM